Century Health, a health technology startup developing an AI-powered platform to unlock high-quality datasets from fragmented and siloed clinical information to fuel groundbreaking research, raised $5 million in a Seed round led by Origin Ventures, with participation from new investors InnovateHealth Ventures, 25madison, and Next Play Ventures, and continuing investors 2048 Ventures and Alumni Ventures.
Strategic angel investors in the round include Zorba Lieberman, founder of Citeline, and clinicians across nephrology, neurology, and ophthalmology.
Century Health will use fresh funds to scale collaborations and use cases with pharmaceutical and life sciences partners, grow its specialty provider data network, and expand its AI-powered data curation infrastructure.
“Century Health is accelerating medical breakthroughs by unlocking real-world clinical data across the entire drug lifecycle, creating a win-win for providers and life sciences companies,” said Prashant Shukla, Partner at Origin Ventures.
“Upstream, it’s the fuel for AI models driving discovery, disease modeling, and patient stratification; downstream, it’s the evidence needed to demonstrate safety and effectiveness, differentiate their drugs, and win payer negotiations.”
Digital health companies, including AI-powered clinical research technology startups, have secured more than $180 billion in funding to date, according to our latest Funding Database.
Notable recent funding rounds include:
- Iterative Health, an AI-powered healthcare technology and services company powering the acceleration of clinical research, raised $77 million in a Series C financing round.
- Dandelion Health, a provider of a clinical intelligence platform for life sciences that powers the next generation of diagnosis and treatments, raised $14 million in a Series A funding round led by Healthier Capital.
- Aidoc, a global leader in enterprise-scale clinical AI focused on helping physicians make earlier, safer diagnoses by turning raw patient signals into actionable insight, raised $150 million in a Series E funding round.